No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs7515963 |
chr1:225665284-225665285 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs547467868 |
chr1:225665287-225665288 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs367721920 |
chr1:225665335-225665336 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs530141789 |
chr1:225665339-225665340 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs548623406 |
chr1:225665382-225665383 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs371471137 |
chr1:225665393-225665394 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs78493289 |
chr1:225665395-225665396 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs35971678 |
chr1:225665435-225665436 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs200383182 |
chr1:225665443-225665444 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs558856175 |
chr1:225665468-225665469 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs36124848 |
chr1:225665478-225665479 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs562314135 |
chr1:225665490-225665491 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs570799288 |
chr1:225665505-225665506 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs115815727 |
chr1:225665531-225665532 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs79431135 |
chr1:225665649-225665650 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs6676201 |
chr1:225665694-225665695 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
17 |
rs541573145 |
chr1:225665706-225665707 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs6678806 |
chr1:225665749-225665750 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
19 |
rs3904736 |
chr1:225665807-225665808 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs192031769 |
chr1:225665821-225665822 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs3904737 |
chr1:225665841-225665842 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs545020347 |
chr1:225665860-225665861 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs35250604 |
chr1:225665901-225665902 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs540475481 |
chr1:225665905-225665906 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs559498876 |
chr1:225665912-225665913 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs530071900 |
chr1:225665916-225665917 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs548415044 |
chr1:225665920-225665921 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs563426025 |
chr1:225665929-225665930 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs531049708 |
chr1:225665933-225665934 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs375603082 |
chr1:225665962-225665963 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs552349420 |
chr1:225665988-225665989 |
Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs375232880 |
chr1:225666071-225666072 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs147114353 |
chr1:225666118-225666119 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs535015346 |
chr1:225666141-225666142 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs138452527 |
chr1:225666175-225666176 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs564997379 |
chr1:225666201-225666202 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs115254918 |
chr1:225666240-225666241 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs78202750 |
chr1:225666243-225666244 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs369986295 |
chr1:225666246-225666247 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs369189756 |
chr1:225666251-225666252 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs186759697 |
chr1:225666261-225666262 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs572005350 |
chr1:225666283-225666284 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs575404098 |
chr1:225666299-225666300 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs539693276 |
chr1:225666325-225666326 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs149619504 |
chr1:225666356-225666357 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs114168738 |
chr1:225666389-225666390 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs540173444 |
chr1:225666393-225666394 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs560454392 |
chr1:225666394-225666395 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs116415296 |
chr1:225666401-225666402 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs374441111 |
chr1:225666411-225666412 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|